Developing A Strategy to Combat Drug Abuse in Philadelphia, 1960-1973 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Developing A Strategy to Combat Drug Abuse in Philadelphia, 1960-1973 PDF full book. Access full book title Developing A Strategy to Combat Drug Abuse in Philadelphia, 1960-1973 by Andrew J. Lippert. Download full books in PDF and EPUB format.
Author: Andrew J. Lippert Publisher: ISBN: Category : Languages : en Pages : 403
Book Description
How did Philadelphia develop its first drug control strategy between 1960 and 1973? This study argues that Philadelphia's drug control strategy was part of an array of collaborative responses to the composite challenges of urban decay and was influenced by concerns for development, law enforcement, and fiscal survival. In the early 1960s, a focus on development and a combination of overt racism and the more subtle psychological process of racial othering made drug abuse a low-priority, policy issue in Philadelphia. At mid-decade, the growing institutionalization of law enforcement overshadowed additional attention drug abuse might have gained at that point. By 1970, "White involvement," as Medical Examiner Joseph Spelman termed it, provided the impetus for a more active and institutionalized public response. As the nation progressed from a War on Poverty, to a War on Crime, and then to a War on Drugs, problems of sustainability and fiscal exhaustion became paramount. When Philadelphia's Coordinating Office for Drug and Alcohol Abuse Programs produced its Comprehensive Plan for Drug and Alcohol Abuse Treatment and Prevention, 1973-1974, it codified a years-long, work-in-progress to address the complex adaptive system that substance abuse represented. Though the strategy did not rectify the larger environmental issues of race, stability, and sustainability with which Philadelphia contended, it did provide a balanced approach and a starting point for future implementation and refinement.
Author: Andrew J. Lippert Publisher: ISBN: Category : Languages : en Pages : 403
Book Description
How did Philadelphia develop its first drug control strategy between 1960 and 1973? This study argues that Philadelphia's drug control strategy was part of an array of collaborative responses to the composite challenges of urban decay and was influenced by concerns for development, law enforcement, and fiscal survival. In the early 1960s, a focus on development and a combination of overt racism and the more subtle psychological process of racial othering made drug abuse a low-priority, policy issue in Philadelphia. At mid-decade, the growing institutionalization of law enforcement overshadowed additional attention drug abuse might have gained at that point. By 1970, "White involvement," as Medical Examiner Joseph Spelman termed it, provided the impetus for a more active and institutionalized public response. As the nation progressed from a War on Poverty, to a War on Crime, and then to a War on Drugs, problems of sustainability and fiscal exhaustion became paramount. When Philadelphia's Coordinating Office for Drug and Alcohol Abuse Programs produced its Comprehensive Plan for Drug and Alcohol Abuse Treatment and Prevention, 1973-1974, it codified a years-long, work-in-progress to address the complex adaptive system that substance abuse represented. Though the strategy did not rectify the larger environmental issues of race, stability, and sustainability with which Philadelphia contended, it did provide a balanced approach and a starting point for future implementation and refinement.
Author: Institute of Medicine Publisher: National Academies Press ISBN: 0309176581 Category : Medical Languages : en Pages : 250
Book Description
For nearly three decades, methadone hydrochloride has been the primary means of treating opiate addiction. Today, about 115,000 people receive such treatment, and thousands more have benefited from it in the past. Even though methadone's effectiveness has been well established, its use remains controversial, a fact reflected by the extensive regulation of its manufacturing, labeling, distribution, and use. The Food and Drug Administration regulates the safety and effectiveness of methadone, as it does for all drugs, and the Drug Enforcement Administration regulates it as a controlled substance. However, methadone is also subjected to a unique additional tier of regulation that prescribes how and under what circumstances it may be used to treat opiate addiction. Federal Regulation of Methadone Treatment examines current Department of Health and Human Services standards for narcotic addiction treatment and the regulation of methadone treatment programs pursuant to those standards. The book includes an evaluation of the effect of federal regulations on the provision of methadone treatment services and an exploration of options for modifying the regulations to allow optimal clinical practice. The volume also includes an assessment of alternatives to the existing regulations.
Author: Committee for the Substance Abuse Coverage Study Publisher: National Academies Press ISBN: 9780309043960 Category : Medical Languages : en Pages : 332
Book Description
Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.
Author: Dean T. Jamison Publisher: World Bank Publications ISBN: 0821361805 Category : Medical Languages : en Pages : 1449
Book Description
Based on careful analysis of burden of disease and the costs ofinterventions, this second edition of 'Disease Control Priorities in Developing Countries, 2nd edition' highlights achievable priorities; measures progresstoward providing efficient, equitable care; promotes cost-effectiveinterventions to targeted populations; and encourages integrated effortsto optimize health. Nearly 500 experts - scientists, epidemiologists, health economists,academicians, and public health practitioners - from around the worldcontributed to the data sources and methodologies, and identifiedchallenges and priorities, resulting in this integrated, comprehensivereference volume on the state of health in developing countries.
Author: National Academies of Sciences, Engineering, and Medicine Publisher: National Academies Press ISBN: 0309452961 Category : Medical Languages : en Pages : 583
Book Description
In the United States, some populations suffer from far greater disparities in health than others. Those disparities are caused not only by fundamental differences in health status across segments of the population, but also because of inequities in factors that impact health status, so-called determinants of health. Only part of an individual's health status depends on his or her behavior and choice; community-wide problems like poverty, unemployment, poor education, inadequate housing, poor public transportation, interpersonal violence, and decaying neighborhoods also contribute to health inequities, as well as the historic and ongoing interplay of structures, policies, and norms that shape lives. When these factors are not optimal in a community, it does not mean they are intractable: such inequities can be mitigated by social policies that can shape health in powerful ways. Communities in Action: Pathways to Health Equity seeks to delineate the causes of and the solutions to health inequities in the United States. This report focuses on what communities can do to promote health equity, what actions are needed by the many and varied stakeholders that are part of communities or support them, as well as the root causes and structural barriers that need to be overcome.
Author: Institute of Medicine Publisher: National Academies Press ISBN: 0309055334 Category : Medical Languages : en Pages : 330
Book Description
Drug abuse persists as one of the most costly and contentious problems on the nation's agenda. Pathways of Addiction meets the need for a clear and thoughtful national research agenda that will yield the greatest benefit from today's limited resources. The committee makes its recommendations within the public health framework and incorporates diverse fields of inquiry and a range of policy positions. It examines both the demand and supply aspects of drug abuse. Pathways of Addiction offers a fact-filled, highly readable examination of drug abuse issues in the United States, describing findings and outlining research needs in the areas of behavioral and neurobiological foundations of drug abuse. The book covers the epidemiology and etiology of drug abuse and discusses several of its most troubling health and social consequences, including HIV, violence, and harm to children. Pathways of Addiction looks at the efficacy of different prevention interventions and the many advances that have been made in treatment research in the past 20 years. The book also examines drug treatment in the criminal justice setting and the effectiveness of drug treatment under managed care. The committee advocates systematic study of the laws by which the nation attempts to control drug use and identifies the research questions most germane to public policy. Pathways of Addiction provides a strategic outline for wise investment of the nation's research resources in drug abuse. This comprehensive and accessible volume will have widespread relevanceâ€"to policymakers, researchers, research administrators, foundation decisionmakers, healthcare professionals, faculty and students, and concerned individuals.
Author: Wan Tang Publisher: Springer Science & Business Media ISBN: 1461443229 Category : Medical Languages : en Pages : 256
Book Description
This volume covers classic as well as cutting-edge topics on the analysis of clinical trial data in biomedical and psychosocial research and discusses each topic in an expository and user-friendly fashion. The intent of the book is to provide an overview of the primary statistical and data analytic issues associated with each of the selected topics, followed by a discussion of approaches for tackling such issues and available software packages for carrying out analyses. While classic topics such as survival data analysis, analysis of diagnostic test data and assessment of measurement reliability are well known and covered in depth by available topic-specific texts, this volume serves a different purpose: it provides a quick introduction to each topic for self-learning, particularly for those who have not done any formal coursework on a given topic but must learn it due to its relevance to their multidisciplinary research. In addition, the chapters on these classic topics will reflect issues particularly relevant to modern clinical trials such as longitudinal designs and new methods for analyzing data from such study designs. The coverage of these topics provides a quick introduction to these important statistical issues and methods for addressing them. As with the classic topics, this part of the volume on modern topics will enable researchers to grasp the statistical methods for addressing these emerging issues underlying modern clinical trials and to apply them to their research studies.
Author: Andrew J. Lippert
Author: Andrew J. Lippert
Author: Institute of Medicine
Author: National Institute on Drug Abuse. Division of Research
Author: Committee for the Substance Abuse Coverage Study
Author: Dean T. Jamison
Author: National Academies of Sciences, Engineering, and Medicine
Author: Institute of Medicine
Author: 
Author: 
Author: Wan Tang